Glioblastomas - Study Using Molecular Markers

Authors

  • Bon EI Candidate of Biological Science, Assistant Professor of Pathophysiology department named D.A. Maslakov, Grodno State Medical University, Repablic of Belarus Author
  • B Th Vihanga A 3rd-Year Student-Group of Faculty of Foreign Students Grodnok Statek Medicalm University, Republic of Belarus Author

DOI:

https://doi.org/10.47363/JDDT/2022(2)106

Keywords:

Glioblastoma, Glioblastoma Markers, Glioblastoma Multiform, GBM

Abstract

Glioblastoma is a lethal tumor that can develop in the central nervous system. The most serious type of brain cancer is known as glioblastoma multiforme (GBM). This work aims to emphasize the usage of different glioblastoma markers during the diagnosis process and the treatment of the GBM. And also this may focus on the changes that are often associated with GBM pathogenesis and understanding the significance of glioblastoma markers, as well as their involvement in numerous critical cellular signaling pathways, can help direct potential research toward novel GBM treatments.

Author Biography

  • Bon EI, Candidate of Biological Science, Assistant Professor of Pathophysiology department named D.A. Maslakov, Grodno State Medical University, Repablic of Belarus

    Lizaveta I. Bon, Candidate of biological science, assistant professor of pathophysiology department named D.A. Maslakov, Grodno State Medical University, Grodno State Medical University, 80, Gorky St., 230009, Grodno, Belarus

Downloads

Published

2022-03-21

Issue

Vol. 2 No. 1 (2022): Volume 2 Issue 1

Section

Articles